Menu

To set up a press or media interview with this expert contact:

Brandie Campbell

Email: bcampbell@phi.org

Biography

Lori Dorfman was BMSG’s first associate director in 1993 and became director in 1998. She earned her doctorate in 1994 from the University of California, Berkeley, School of Public Health, where she studied how television news frames health issues. Dorfman oversees BMSG’s research, media advocacy training, strategic consultation, and education for journalists and consults with programs across the U.S. on a variety of public health issues, helping them apply the principles of media advocacy. Her research examines media portrayals of public health issues, including children’s health, food and beverage marketing, nutrition, breastfeeding, violence, and alcohol, tobacco and other drugs. She co-authored the major texts on media advocacy: Media Advocacy and Public Health: Power for Prevention and News for a Change: An Advocate’s Guide to Working with the Media; she edited Reporting on Violence: A Handbook for Journalists, which encourages journalists to include a public health perspective in violence reporting and led an interdisciplinary team that conducted workshops on violence reporting for newspapers and local TV news stations. She teaches a course on mass communication at the University of California, Berkeley, School of Public Health. Dorfman co-chairs the Food Marketing Workgroup, a national coalition dedicated to eliminating harmful food marketing.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org